会议详情 |
摘要提交截止日期:2019年12月4日
1. GYNECOLOGICAL ENDOCRINOLOGY
1.1 Reproductive Neuroendocrinology
1.1 Regulation of the HPG axis
1.2 FSH and LH receptors
1.3 Hyperprolactinemia
1.4 GnRH analogues and antagonists
1.5 Steroids and steroid receptors signaling mechanisms
1.6 Biological actions of progestins
1.7 Androgens and hyperandrogenisms
1.8 Primary and secondary amenorrhea
1.9 Polycystic ovary syndrome
1.10 Insulin resistance
1.11 Obesity, metabolic syndrome
1.12 Pediatric and adolescent endocrinology
1.13 Thyroid diseases
1.14 Endocrine disorders and woman’s health
1.15 Endocrine disruptors
1.16 Selective steroid receptor modulators
2. CONTRACEPTION
2.1 New compounds for contraception
2.2 Non-contraceptive benefits of contraceptives
2.3 Male contraception
2.4 Emergency contraception
2.5 Medical and surgical abortion
2.6 Intrauterine contraceptives
2.7 Contraception and adolescents
2.8 Contraception and perimenopause
2.9 Therapeutic uses of HC
2.10 Long lasting contraception
3. MEDICALLY ASSISTED PROCREATION
3.1 Embryo implantation and development
3.2 Stem cells and human reproduction
3.3 Mechanisms of follicle selection and development
3.4 Reproduction, the Immune system and oxidative stress
3.5 The infertile couple
3.6 Techniques in MAP
3.7 Ovulation induction
3.8 Ovarian hyperstimulation
3.9 Endometriosis and assisted reproduction
3.10 The anovulatory patient
3.11 Endocrine disorders and medically assisted procreation
3.12 Adnexal diseases and MAP
3.13 Fertility preservation
3.14 Autologue and heterologue donation
3.15 MAP and ethics
3.16 MAP in premature ovarian insufficiency
3.17 Time Laps
3.18 PGD/PGS
4. OBSTETRICS
4.1 Recurrent abortion
4.2 Extra-uterine pregnancy
4.3 Prenatal diagnosis
4.4 Prenatal medicine
4.5 The placenta and the fetal membranes
4.6 The thyroid and pregnancy
4.7 Immunological disorders and pregnancy
4.8 Endocrine disorders in pregnancy
4.9 Neurodegenerative disorders in pregnancy
4.10 Insulin resistance and obstetric diseases
4.11 Obesity and fetal and maternal risks
4.12 Pregnancy and lifestyle
4.13 Preterm labor and delivery
4.14 Gestational hypertension, pre-eclampsia and eclampsia
4.15 Gestational Diabetes Mellitus
4.16 Normal and abnormal intrauterine growth
4.17 Infectious diseases and pregnancy
4.18 Twin and multiple pregnancies
4.19 Labor induction
4.20 Caesarean Section: pro and con
4.21 Fetal origins of adult diseases
4.22 Postpartum management of high risk
pregnancies
5. GYNECOLOGY
5.1 Stem cells in gynecology
5.2 Angiogenesis and gynecological diseases
5.3 Puberty and adolescent gynecology
5.4 Female sexual function and dysfunction
5.5 Sexually transmitted diseases
5.6 Hormones and gynecological disorders
5.7 Endometrial regulation
5.8 Abnormal uterine bleeding
5.9 Pelvic pain
5.10 Endometrial hyperplasia
5.11 Endometriosis: genetics and hormones
5.12 Medical treatments for endometriosis
5.12 Adenomyosis
5.13 Uterine myomas, medical and surgical
management
5.14 Clinical management of adnexal cysts
5.15 Vulvar and vaginal lesions
6. MENOPAUSE AND AGEING
6.1 Steroid hormones and ageing
6.2 Neurotoxicity, neuronal survival and
hormone protection
6.3 The climacteric syndrome
6.4 Menopause, HRT and CVD
6.5 Menopause, HRT and cancers
6.6 Menopause, HRT and neurodegenerative diseases
6.7 Postmenopausal osteoporosis
6.8 Bisphosphonates, PTH and the boneforming agents
6.9 Selective estrogen receptor modulators
SERM’s
6.10 Progesterone, progestins SPRM’s
6.11 Androgen therapy
6.12 Bio-identical treatments
6.13 Non-hormonal treatments for climacteric women
6.14 Sexual health and dysfunction
6.15 Phytoestrogens
6.16 Plant extrats and steroid receptors
7. GYNECOLOGICAL ONCOLOGY
7.1 Genes and gynecological cancers
7.2 Hormones and gynecological cancers
7.3 Stem cells and gynecological
malignancies
7.4 Proteomics for cancer diagnosis and
treatment
7.5 Screenings and for gynecological cancers
7.6 HPV and HPV vaccines
7.7 Border-line and pre-tumoral lesions
7.8 Clinical management of gynecological
cancers
7.9 Conservative approaches to gynecological
cancers
7.10 New concepts in radio/chemotherapy
7.11 Hormonal therapies for gynecological
cancers
7.12 Pregnancy and cancer
8. THE BREAST
8.1 Breast development and function
8.2 Hormones and the breast
8.3 Benign breast diseases, contraception
and HRT
8.4 Breast carcinogenesis
8.5 Hormones, breast cancer proliferation
and metastasis
8.6 New prognostic and predictive factors
8.7 Anti-estrogens, SERMs and aromatase
inhibitors
8.8 Oncological and aesthetic breast surgery
8.9 Breast cancer and pregnancy
9. GYNECOLOGICAL SURGERY
9.1 Vaginal approaches to pelvic diseases
9.2 Urinary incontinence
9.3 New techniques for pelvic floor defects
correction
9.4 Laparoscopic treatment of pelvic masses
9.5 Laparoscopy, endometriosis
and reproduction
9.6 New treatments of uterine myomas
9.7 Sentinel node biopsy in gynecological
cancers
9.8 Oncological applications of aparoscopy
9.9 Robotic surgery in gynecology
9.10 Multidisciplinary approach to the pelvic floor
10. DIAGNOSIS
10.1 Ultrasound in gynecology and obstetrics
10.2 Interventional ultrasound techniques
10.3 Hysteroscopy
10.4 Colposcopy
10.5 Laparoscopy
声明:
1、以上会议非活动家网站主办或承办会议,活动家网站学术会议频道会议信息来自于今日会议网,方便用户了解行业信息,如需参会、报名、获取会议邀请函或会议日程,请直接与学术会议活动主办单位联系。
2、部分会议内容来自互联网,由于网络的不确定性,活动家网站对所发布的信息不承担真实性的鉴别工作,请谨慎选择。若您发现会议页面信息有误,请联系活动家客服028-69761252纠错。
相关会议
2025-04-25深圳
2025-04-16北京